STUDIES OF MAGNESIUM AND PHOSPHORUS COMBINED MEDICATION BASED ON CASEIN

Aim. The Department of Biochemistry and Physiology of Animals, named after Academician Guly NUBIP of Ukraine, developed magnesium and phosphorus combined medication based on casein. Our aim was to test its bioavailability based on the ability to be hydrolyzed by a mixture of pancreatic digestive enz...

Full description

Bibliographic Details
Main Authors: Palonko R.I., Pavlyuk O.V., Arnauta O.V., Kalachniuk L.H.
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2021-10-01
Series:Biotechnologia Acta
Subjects:
Online Access:http://biotechnology.kiev.ua/images/5_2021/palonko_5_2021.pdf
_version_ 1797766857404448768
author Palonko R.I.
Pavlyuk O.V.,
Arnauta O.V.
Kalachniuk L.H.
author_facet Palonko R.I.
Pavlyuk O.V.,
Arnauta O.V.
Kalachniuk L.H.
author_sort Palonko R.I.
collection DOAJ
description Aim. The Department of Biochemistry and Physiology of Animals, named after Academician Guly NUBIP of Ukraine, developed magnesium and phosphorus combined medication based on casein. Our aim was to test its bioavailability based on the ability to be hydrolyzed by a mixture of pancreatic digestive enzymes trypsin and chymotrypsin, also check the absence of cytotoxic effects on cell cultures. Methods. To assess bioavailability, we used hydrolysis of the medication with a mixture of trypsin and chymotrypsin, followed by detection of hydrolysis products by polyacrylamide gel electrophoresis. A standard MTT-test performed on both MT-4 and Namalva cell lines was used to assess cytotoxic effects. Results. Based on electrophoresis data, it was found that despite chemical modifications of the natural casein, the medication based on it is characterized by a high ability to hydrolyze by digestive enzymes under the same conditions as casein. Also, an MTT-test demonstrates that the medication has no cytotoxic properties against cell lines MT-4 and Namalva. Conclusions. Since the negative effects of the drug associated with its digestibility and toxicity have not been observed, it is recommended to continue the study of its effects on living organisms.
first_indexed 2024-03-12T20:31:19Z
format Article
id doaj.art-6c952f75c5a544178c08857100ad5a76
institution Directory Open Access Journal
issn 2410-7751
2410-776X
language English
last_indexed 2024-03-12T20:31:19Z
publishDate 2021-10-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series Biotechnologia Acta
spelling doaj.art-6c952f75c5a544178c08857100ad5a762023-08-02T00:03:03ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryBiotechnologia Acta2410-77512410-776X2021-10-01145566210.15407/biotech14.05.056STUDIES OF MAGNESIUM AND PHOSPHORUS COMBINED MEDICATION BASED ON CASEINPalonko R.I.0Pavlyuk O.V.,1Arnauta O.V.2 Kalachniuk L.H.3National University of Life and Environmental Sciences of UkraineNational University of Life and Environmental Sciences of UkraineNational University of Life and Environmental Sciences of UkraineNational University of Life and Environmental Sciences of UkraineAim. The Department of Biochemistry and Physiology of Animals, named after Academician Guly NUBIP of Ukraine, developed magnesium and phosphorus combined medication based on casein. Our aim was to test its bioavailability based on the ability to be hydrolyzed by a mixture of pancreatic digestive enzymes trypsin and chymotrypsin, also check the absence of cytotoxic effects on cell cultures. Methods. To assess bioavailability, we used hydrolysis of the medication with a mixture of trypsin and chymotrypsin, followed by detection of hydrolysis products by polyacrylamide gel electrophoresis. A standard MTT-test performed on both MT-4 and Namalva cell lines was used to assess cytotoxic effects. Results. Based on electrophoresis data, it was found that despite chemical modifications of the natural casein, the medication based on it is characterized by a high ability to hydrolyze by digestive enzymes under the same conditions as casein. Also, an MTT-test demonstrates that the medication has no cytotoxic properties against cell lines MT-4 and Namalva. Conclusions. Since the negative effects of the drug associated with its digestibility and toxicity have not been observed, it is recommended to continue the study of its effects on living organisms.http://biotechnology.kiev.ua/images/5_2021/palonko_5_2021.pdfkey words: magnesiumphosphoruscaseinchelatein vitrohydrolysiscell culturecytotoxicitymtt reagentnadh (nicotinamide adenine dinucleotide).
spellingShingle Palonko R.I.
Pavlyuk O.V.,
Arnauta O.V.
Kalachniuk L.H.
STUDIES OF MAGNESIUM AND PHOSPHORUS COMBINED MEDICATION BASED ON CASEIN
Biotechnologia Acta
key words: magnesium
phosphorus
casein
chelate
in vitro
hydrolysis
cell culture
cytotoxicity
mtt reagent
nadh (nicotinamide adenine dinucleotide).
title STUDIES OF MAGNESIUM AND PHOSPHORUS COMBINED MEDICATION BASED ON CASEIN
title_full STUDIES OF MAGNESIUM AND PHOSPHORUS COMBINED MEDICATION BASED ON CASEIN
title_fullStr STUDIES OF MAGNESIUM AND PHOSPHORUS COMBINED MEDICATION BASED ON CASEIN
title_full_unstemmed STUDIES OF MAGNESIUM AND PHOSPHORUS COMBINED MEDICATION BASED ON CASEIN
title_short STUDIES OF MAGNESIUM AND PHOSPHORUS COMBINED MEDICATION BASED ON CASEIN
title_sort studies of magnesium and phosphorus combined medication based on casein
topic key words: magnesium
phosphorus
casein
chelate
in vitro
hydrolysis
cell culture
cytotoxicity
mtt reagent
nadh (nicotinamide adenine dinucleotide).
url http://biotechnology.kiev.ua/images/5_2021/palonko_5_2021.pdf
work_keys_str_mv AT palonkori studiesofmagnesiumandphosphoruscombinedmedicationbasedoncasein
AT pavlyukov studiesofmagnesiumandphosphoruscombinedmedicationbasedoncasein
AT arnautaov studiesofmagnesiumandphosphoruscombinedmedicationbasedoncasein
AT kalachniuklh studiesofmagnesiumandphosphoruscombinedmedicationbasedoncasein